Category: Interview
-
Building sustainable medical products: Polaroid exec on innovation and challenges
Head of Product at Polaroid Therapeutics, Paul Saunders, shares his approach to embedding sustainability in healthcare innovation.
-
Sustainability by design: Allegro CEO on greener medical innovation
Lucas Decuypere, CEO of the Belgian MedTech company, on making sustainability a core part of medical product design from day one.
-
More regulations needed to increase transparency in sustainability reporting
Swiss CDMO ten23 health’s CEO talks about challenges in sustainability reporting and his approach to environmental sustainability.
Latest posts
-
Navigating the Risks and Rewards of Biomarker-Based Surrogates and Accelerated Approval
The risks and rewards of biomarker-based surrogates are crucial for optimizing clinical trial outcomes and guiding effective treatments.
-
ASH25: Gallop’s LYT-200 shows unprecedented survival in AML
The company’s execs talk about the striking efficacy and safety signals seen in Phase I data, the science behind the molecule, and their vision for transforming AML therapy.
-
Promis reports first human evidence of aβ oligomer reduction by pmn310
PMN310 demonstrates dose-dependent reduction of amyloid-beta oligomers in human CSF, marking a key milestone in Alzheimer’s treatment development.
-
Urologic Health secures $11 million for non-invasive bladder monitoring
Urologic Health raises $11million seed funding to advance a catheter-free bladder monitoring platform toward FDA clearance and US market entry.
-
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors
Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.